Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-022400

Chief Legal Officer acquired 36,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Mazzariello Gina Chief Legal Officer 2024-02-26 Grant or award +36,667 82,912 D
Derivatives
Mazzariello Gina Chief Legal Officer 2024-02-26 Grant or award · Stock Option (right to buy) +55,000 55,000 D
Loading xslF345X05/ownership.xml…